Albireo Pharma, Inc. ALBO
44.15 +44.15
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2021 · select a line to chart its full history
Income statement
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 40.58M | 8.31M | 9.64M | 12.74M | 1.00K | |
| 39.22M | 8.31M | 9.64M | 12.74M | 1.00K | |
| -123.48M | -96.27M | -61.11M | -37.89M | -24.58M | |
| -34.03M | -107.63M | -62.72M | -46.11M | -24.41M | |
| -1.77 | -6.73 | -5.04 | -3.94 | -3.12 |
Balance sheet
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 248.11M | 251.27M | 131.84M | 163.88M | 53.23M | |
| 302.05M | 285.61M | 165.07M | 185.47M | 73.22M | |
| 126.44M | 104.38M | 71.91M | 62.83M | 7.97M | |
| 10.00M | 9.62M | 0 | 0 | 0 | |
| 175.61M | 181.23M | 93.16M | 122.64M | 65.25M |
Cash flow
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| -107.56M | -101.03M | -52.92M | -26.80M | -27.57M | |
| 102.92M | -78.00K | -540.00K | -47.00K | 4.31M | |
| 2.76M | 220.28M | 23.50M | 139.18M | 45.84M | |
| -465.00K | -78.00K | -540.00K | -47.00K | 4.31M | |
| -3.17M | 119.43M | -32.04M | 110.65M | 23.30M |